OMNIlife science™, Inc. Achieves Milestone with OMNIBotics® Active Spacer 1,000 Cases Completed with First Predictive Ligament Balancing Robot RAYNHAM, Mass., Oct. 3, 2018 /PRNewswire/ -- OMNIlife science, Inc. ("OMNI"), a...

RAYNHAM, Mass., Oct. 3, 2018 /PRNewswire/ -- OMNIlife science, Inc. ("OMNI"), a privately-held medical technology company targeting the $15 billion global hip and knee replacement device market, reported today that the positive clinical...

PLEASE JOIN US FOR A CANDID DISCUSSION ON OPTIONS FOR TOTAL KNEE REPLACEMENT - GIVEN BY DR. JEFFREY H. DECLAIRE, MD Jeffrey H. DeClaire, M.D. is a board-certified and fellowship-trained...